X
Record #3725

Immunohistochemical prognostic markers in diffuse large B-cell lymphoma: validation of tissue microarray as a prerequisite for broad clinical applications (a study from the Lunenburg Lymphoma Biomarker Consortium)

Original paper date
Sep 15, 2008
Institution
The Netherlands Cancer Institute, Amsterdam · Dana-Farber Cancer Institute, Boston, Massachusetts · Institute of Pathology, University of Würzburg, Würzburg · British Columbia Cancer Agency, University of British Columbia, Vancouver · Department of Pathology, Inserm U617, Hôpital Henri Mondor, Créteil · Department of Pathology, Hematopathology Section, University Hospital Schleswig-Holstein, Campus Kiel · CRUK Medical Oncology Unit, St Bartholomew’s Hospital, London · Karolinska Institutet, Stockholm · University Clinic Schleswig-Holstein, Campus Lübeck · Hospital Clinic, University of Barcelona, Barcelona · Université Paris-Descartes · AP-HP, Hôtel-Dieu, Paris · Academic Medical Center, Amsterdam · Stanford University Medical Center, Palo Alto, California · St Bartholomew’s Hospital, Department of Medical Oncology, London · University Medical Center Nijmegen · Hospices Civils de Lyon and Université Claude Bernard Lyon-1, Lyon
Open access
No
Article type
Research Article
Broad categories
(BLS) Biochemistry(BLS) Biology - Cancer(HSC) Medicine - Oncology(HSC) Medicine - Pathology
Citation lifecycle

How this paper is being cited

Pre-retraction
56
Same day
0
Post-retraction
68
% post-retraction
54.8%
~14.2 citations/yr before retraction · ~4.8 citations/yr after
— citing papers

Who is still citing this work

Loading…
Back to browse